4-iodoamphetamine has been researched along with 8-hydroxy-2-(di-n-propylamino)tetralin in 1 studies
| Studies (4-iodoamphetamine) | Trials (4-iodoamphetamine) | Recent Studies (post-2010) (4-iodoamphetamine) | Studies (8-hydroxy-2-(di-n-propylamino)tetralin) | Trials (8-hydroxy-2-(di-n-propylamino)tetralin) | Recent Studies (post-2010) (8-hydroxy-2-(di-n-propylamino)tetralin) |
|---|---|---|---|---|---|
| 100 | 4 | 16 | 3,530 | 7 | 389 |
| Protein | Taxonomy | 4-iodoamphetamine (IC50) | 8-hydroxy-2-(di-n-propylamino)tetralin (IC50) |
|---|---|---|---|
| 5-hydroxytryptamine receptor 1A | Homo sapiens (human) | 0.0012 | |
| 5-hydroxytryptamine receptor 1A | Rattus norvegicus (Norway rat) | 0.0032 | |
| Alpha-2B adrenergic receptor | Rattus norvegicus (Norway rat) | 0.81 | |
| D(2) dopamine receptor | Bos taurus (cattle) | 0.8 | |
| Alpha-2C adrenergic receptor | Rattus norvegicus (Norway rat) | 0.81 | |
| Alpha-2A adrenergic receptor | Rattus norvegicus (Norway rat) | 0.81 | |
| D(2) dopamine receptor | Rattus norvegicus (Norway rat) | 2.8959 | |
| Lysosomal alpha-glucosidase | Bos taurus (cattle) | 0.0021 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alter, SP; Guillot, TS; Lohr, KM; Miller, GW; Shepherd, KR; Stout, KA; Taylor, TN; Wang, M | 1 |
1 other study(ies) available for 4-iodoamphetamine and 8-hydroxy-2-(di-n-propylamino)tetralin
| Article | Year |
|---|---|
Reduced vesicular monoamine transport disrupts serotonin signaling but does not cause serotonergic degeneration.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Amphetamines; Animals; Corpus Striatum; Mice; Mice, Transgenic; Nerve Degeneration; Neurons; Receptor, Serotonin, 5-HT1A; Serotonin; Vesicular Monoamine Transport Proteins | 2016 |